Rani Therapeutics Holdings, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
23.63
|
|
Average Rating
|
4.88
|
|
# Strong Buys
|
7
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.48
|
0.00
|
0.48
|
100.00%
|
|
2022-12-31
|
-0.41
|
0.00
|
0.41
|
100.00%
|
|
2022-09-30
|
-0.47
|
-0.33
|
0.14
|
29.79%
|
|
2022-06-30
|
-0.58
|
-0.31
|
0.27
|
46.55%
|
|
2022-03-31
|
-0.66
|
-0.29
|
0.37
|
56.06%
|
|
2021-12-31
|
-0.49
|
-0.27
|
0.22
|
44.90%
|
|
2021-09-30
|
-0.18
|
-0.12
|
0.06
|
33.33%
|
|
2021-06-30
|
-0.18
|
-0.12
|
0.06
|
33.33%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.93
|
|
2021-12-31
|
-0.63
|
|
2020-12-31
|
-0.12
|
|
2019-12-31
|
-0.11
|